Vaccine against Ebola: Commission grants new market authorisations

Ebola vaccine

(Credit: Unsplash)

This article is brought to you in association with the European Commission.


Today, the European Commission adopted the decision granting marketing authorisations to the company Janssen, a Johnson & Johnson company, for a vaccine against Ebola. The authorisation was granted in one month, reducing the decision-making process timing in half, further demonstrating the Commission’s commitment in placing the protection of public health as a priority.

The new Ebola vaccine, which consists of two components, called Zabdeno and Mvabea, had been in development with the support of the Commission. This decision follows a recommendation from the European Medicines Agency (EMA), which has assessed the benefits and risks of the vaccine.

Stella Kyriakides, Commissioner in charge of Health and Food Safety, said: “This is the second Ebola vaccine that the Commission authorises in less than a year and confirms once again that the EU remains at the forefront of the global effort to save lives from this virus. We know very well from the coronavirus crisis that viruses do not respect borders – protecting the health of others protects the health of all.”

Mariya Gabriel, Commissioner in charge of Research, said: Today, we can be glad to have supported the development of the Ebola vaccine with EU funding, in partnership with the European pharmaceutical sector under the Innovative Medicines Initiative. The investment from the EU’s research programme Horizon 2020 into several Innovative Medicines Initiative Ebola projects is now bearing fruit. This demonstrates, yet again, the power of collaboration and European R&I leadership to tackle global health threats. “

As explained by EMA when it recommended the approval last February, the ability of the immune system to respond to the virus after vaccination with Zabdeno and Mvabea was studied in a total of 3,367 adults, adolescents and children who participated in five clinical studies conducted in Europe, Africa and the US.

The development of the vaccine is the result of rigorous work by several projects funded with just over €130 million through the Innovative Medicines Initiative (IMI), which is partly supported by the EU’s research and innovation programme, Horizon 2020. Following a comprehensive approach, the EBOVAC 1, 2 & 3, projects assessed the safety and tolerability of the Ebola vaccine regimen through clinical trials in Europe and Africa. The EBODAC project developed a communication strategy and tools to promote the acceptance and uptake of new Ebola vaccines. Finally, the EBOMAN project focused on accelerating the development and manufacture of the vaccine.

Background

The authorisation of a medicine under the centralised procedure is a two-stage process, involving the European Medicines Agency (EMA) and the Commission. EMA assesses the benefits and risks of medicines and makes recommendations to the Commission, which then takes a final legally binding decision on whether or not the medicine can be marketed in the EU.

This decision is issued normally within the legal deadline of 67 days of the scientific opinion of EMA (for Zabdeno and Mvabea the date was 28 May). This phase includes, among other things, the translation of the product guidelines in all EU languages and a consultation with Member States. In view of the public health interest, the Commission has accelerated this process and authorised the medicine in around a month, in other words reducing the time taken for the decision-making process in half.

The assessment report for the vaccines will be published on EMA’s website.

IMI funds large-scale collaborative research projects bringing together academic and industrial partners, as well as patients and other stakeholders.

In November 2014, IMI responded very rapidly to the West Africa outbreak of Ebola by allocating €280 million to a comprehensive call for proposals to tackle a wide range of challenges in Ebola research, including vaccines development, clinical trials, storage and transport, as well as diagnostics. The first projects under the IMI Ebola+ programme started as early as January 2015 and several focused on the development of the Janssen vaccine regimen. Since 2014, IMI has funded 12 projects on Ebola and related diseases with a total combined budget of over EUR 300 million.

the sting Milestone

Featured Stings

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

Discovering Europe: Free EU rail pass for 18 year olds

Radioactive nuclear waste is a global threat. These scientists may have a new solution

These are the 4 most likely scenarios for the future of energy

UN agency chiefs issue ‘call to action’ on behalf of refugee children

7 simple steps we can all take to reduce food waste

State aid: Commission amends Short-term export-credit insurance Communication in light of economic impact of coronavirus outbreak

Quicker freezing and confiscation of criminal assets in the EU

UN updates guidelines to ensure successful return to civilian life for former combatants

80 adolescents a day will still die of AIDS by 2030, despite slowdown in epidemic

‘Well-being of two million’ in Gaza at stake as emergency fuel runs dry: UN humanitarian coordinator

Pedal power makes ‘positive impact on climate’, urges UN on World Bicycle Day

Can Eurozone’s uncertain growth answer the challenges that lie ahead?

Commission: Gifts of €6 billion and free trainees to ‘help’ poor employers

Tackle ‘tsunami of hatred’ across the world urges Guterres, to counter anti-Semitism, racism and intolerance

We need to rethink the way we heat ourselves. Here’s why

Deal agreed to protect consumers against misleading and unfair practices

Quality of air in Bucharest-Romania: is it fog or is it smog?

China is among the 20 most innovative economies for the first time

New General Assembly President brings ‘valuable insights’ into key UN challenges

What if big-tech companies became non-profits?

Syrian crisis: EU mobilises an overall pledge of €6.9 billion for 2020 and beyond

In this Tokyo cafe, the waiters are robots operated remotely by people with disabilities

As urbanisation grows, cities unveil sustainable development solutions on World Day

Workers want flexibility. After COVID, they just might get it: Poll

Eritrea sanctions lifted amid growing rapprochement with Ethiopia: Security Council

‘Grave consequences’ await if new deadly escalation of violence in Gaza continues – top UN official

An ageing workforce isn’t a burden. It’s an opportunity

EU budget 2019 approved: focus on the young, innovation and migration

FIFA and UN kick off healthy living campaign, to harness global game’s ‘huge potential’

EU’s unsparing question to UK: now what kind of future relations do you want?

Guatemala: UN anti-corruption body will continue working, as Constitutional Court blocks Government expulsion

Haiti stands ‘at the crossroads’ between peacekeeping, development – Bachelet urges strengthened ‘human rights protection’

A Brussels antithesis reveals where the EU is heading

EU, Brazil to hold high level Summit in Brasilia

Don’t understand the US-China trade war? This metaphor could help

Amazon: our green is turning to ashes

‘Mosques should be safe havens, not sites of terror’, says Guterres announcing UN plan to help safeguard religious sites

Find unity ‘to halt Libya’s senseless unraveling’, UN envoy urges Security Council

Despite violence, ‘tremendous hunger’ for peace in Afghanistan: top UN official

What does strategy have to do with a platform approach?

COP21 Breaking News: China has promised to cut emissions from its coal power plants by 60% by 2020

How civil society must adapt to survive its greatest challenges

‘Historic’ moment: Palestine takes reins of UN coalition of developing countries

This new form of currency could transform the way we see money

GDPR and the World Cup have these 4 things in common

A ‘strong and united Europe’ has never been more needed, declares UN chief Guterres

South Sudan: UN calls for end to inter-communal clashes, attacks against aid workers

WEF Davos 2016 LIVE: “If we do not do properly the Paris agreement, then all 16 remaining goals will be undermined”, UN Secretary General Ban Ki-moon cautions from Davos

The importance and the need of mobile technology in the health care system and in saving lives.

European Public Prosecutor’s Office: EU Prosecutors take their oath at the European Court of Justice

The United Kingdom’s decision to leave the European Union will impact young people’s future the most

European Union signs aviation agreement with the Republic of Korea

Marriage equality boosted employment of both partners in US gay and lesbian couples

India and the US: 5 ways the countries compare

Unlock the value proposition for Connected Insurance

Trade in counterfeit goods costs UK economy billions of euros

Sochi not far away from Ukraine

ECB: Monetary policy decisions

What the future holds for the EU – China relations?

US-North Korea summit ‘an important milestone’ towards denuclearization, says Guterres

More Stings?

Advertising

Speak your Mind Here

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s